Color provides a more connected, direct, and proactive approach by assessing cancer risk and making screening more accessible, accelerating time to diagnosis, guiding patients through …

Explore Color’s cancer care: early risk detection, at-home screening, expert-led treatment, and survivorship support for better outcomes.

Will my at-home genetic test tell me if I have cancer, high cholesterol, or a heart condition? Will my at-home genetic test tell me if I use the right medications?

Synopsys employees and up to two adult dependents over the age of 18 have complimentary access to Color’s confidential health service to help you personalize your health with genetic …

In 2015, Color launched with a new clinical genetic testing model to help patients understand and take action on their personal risk of cancer. Our first product tested for BRCA1, BRCA2, and …

Ready to take control of cancer? Get in touch. If you’re a patient or member, call us at 844-352-6567. Whether you’re interested in offering Color as a benefit for your organization or you’re …

Women and men who use Color will learn about their genetic risk for hereditary breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.

This test checks 73 genes to give a broad view of how genes may affect one’s health. It can help you and your healthcare providers plan for prevention, early screening, and care that’s right for …

Color’s testing is used by employers, health systems, research institutions, and public health programs to deliver affordable, scalable access to high-quality genetic insights, supporting …

This test cannot be performed if you’ve had a bone marrow transplant from a donor, a blood transfusion within the last 7 days, or currently have a blood cancer.